Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12.4Revenue (TTM) $M6.6Net Margin (%)-30.5Altman Z-Score16.0
Enterprise Value $M4.2EPS (TTM) $-0.1Operating Margin %79.2Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)79.2Higher ROA y-yN
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio26.0Cash flow > EarningsY
Price/Sales1.95-y EBITDA Growth Rate %--Current Ratio26.0Lower Leverage y-yY
Price/Free Cash Flow2.5y-y EBITDA Growth Rate %-40.1ROA % (ttm)-11.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-12.0Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M44.2ROIC % (ttm)-29.8Gross Margin Increase y-yN

Gurus Latest Trades with ENZN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

ENZN is held by these investors:

ENZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ICAHN CARL C10% Owner 2016-11-28Buy694,023$0.41-29.27view
LEBUHN ROBERTDirector 2013-09-19Sell55,926$1.72-83.14view
LEBUHN ROBERTDirector 2012-08-14Sell5,820$6.58-95.59view
LEBUHN ROBERTDirector 2012-08-10Sell1,933$6.58-95.59view
HEBARD GEORGEInterim PEO and Interim COO 2012-06-20Buy5,000$6.88-95.78view
Rackear Andrew D.VP and General Counsel 2012-06-05Sell1,614$6.81-95.74view
Conover CharlesSVP, R&D Program Management 2012-06-05Sell25,000$6.78-95.72view
Young Richard ADirector 2012-03-15Sell2,000$6.92-95.81view
Rackear Andrew D.VP and General Counsel 2011-11-10Sell3,766$6.68-95.66view
Buchbinder AbyVP, Clinical Development 2011-11-08Sell2,700$7.06-95.89view

Quarterly/Annual Reports about ENZN:

News about ENZN:

Articles On GuruFocus.com
Carl Icahn Discloses 20 Million Share Stake in Xerox Spinoff Conduent Jan 10 2017 
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016 
Top Micro-Cap Picks From the Gurus Jun 23 2015 
Baupost’s Seth Klarman Takes 10% Stake in Keryx Biopharmaceuticals May 12 2014 
GuruFocus Real Time Picks of the Week Jan 10 2014 
Seth Klarman Buys New Stock Kindred Biosciences, Cut Stake in Enzon Jan 10 2014 
Billionaires Hold Bargains, 40% Off or More Sep 11 2013 
Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
First Pacific Advisors’ Top New Buys Aug 08 2012 
Enzon Inc. Reports Operating Results (10-K) Mar 16 2011 

More From Other Websites
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 18, 2017 May 18 2017
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017 Mar 28 2017
Carl Icahn Takes 15% Stake in Enzon Pharmaceuticals Dec 02 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 Nov 14 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 Aug 12 2016
OTC Markets Group Welcomes Enzon Pharmaceuticals, Inc. to OTCQX Aug 09 2016
Enzon Pharmaceuticals, Inc. :ENZN-US: Earnings Analysis: 2015 By the Numbers Mar 24 2016
Enzon Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers Dec 10 2015
Guidance & Quarterly Review on Four Biotech Companies Aug 14 2015
Enzon Pharmaceuticals Inc (ENZN)’s Shares Rally After Special Cash Dividend Announcement Jul 06 2015
Voltari Corp (VLTC): Carl Icahn Stirring Yet Another Pot Apr 01 2015
DELiA*s Rebounds As Reports Suggest Delisting May Be Imminent Nov 03 2014
George Soros Picks KIOR, RSH, BIOL Soar On Monday Sep 15 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat